Dextroamphetamine Sulfate 45963-0305-09
- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- June 19, 2014
- Listing Expires
- December 31, 2027
- Application
- ANDA203901
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dextroamphetamine Sulfate | 15 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
45963-0305-09Selected90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (45963-305-09)